SYDNEY, Oct. 14, 2025 /PRNewswire/ -- Approximately 1 million Australian adults have Type 2 diabetes and it is estimated over 2 million people are pre-diabetic or are at high risk of developing the ...
ORLANDO, Fla.--(BUSINESS WIRE)--MITRE announced Compassâ„¢, a first-in-class, open-source application to collect minimal common oncology data elements, or mCODEâ„¢, from electronic health records (EHR), ...
CTX-009 is a bispecific antibody that simultaneously targets Delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF-A). This next generation angiogenesis inhibitor has completed a ...